Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon

Cervical cancer (CC) is the most common type of cancer in women and is the third leading cause of death in most developing countries, causing more than 288,000 deaths in women worldwide each year. The most favourable survival rate is in developed countries, since CC mortality has recently declined i...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2017-11, Vol.12 (11), p.e0187579-e0187579
Main Authors: Carneiro, Saul Rassy, Fagundes, Marcela de Araújo, do Rosário, Pricila de Jesus Oliveira, Neves, Laura Maria Tomazi, Souza, Givago da Silva, Pinheiro, Maria da Conceição Nascimento
Format: Article
Language:English
Subjects:
Biology and Life Sciences
Cancer
Cancer survivors
Care and treatment
Cervical cancer
Cervix
Demographic aspects
Developed countries
Developing countries
Health aspects
Histology
Hospitals
LDCs
Medical diagnosis
Medical prognosis
Medical screening
Medicine and Health Sciences
Metastases
Mortality
Patient outcomes
Patients
People and places
Population
Quality of life
Regional development
Skin cancer
Socioeconomic factors
Squamous cell carcinoma
Survival
Survival analysis
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cervical cancer (CC) is the most common type of cancer in women and is the third leading cause of death in most developing countries, causing more than 288,000 deaths in women worldwide each year. The most favourable survival rate is in developed countries, since CC mortality has recently declined in those countries. The purpose of this study was to determine the survival rate and associated factors of CC patients at a reference hospital in the Amazon region. The patient sample included records of 339 patients with cervical cancer who had been hospitalized in Belém, Pará, Brazil from January 2005 to December 2010; the socioeconomic and clinical data were collected between June and September 2016. A survival rate of approximately 84% was observed, and it was found that disease stage (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0187579